Your browser doesn't support javascript.
loading
Deciding on the best pharmacotherapy for advanced triple-negative breast cancer: expert guidance.
Corvaja, Carla; Taurelli Salimbeni, Beatrice; Nicolò, Eleonora; Puglisi, Fabio; Curigliano, Giuseppe.
Afiliação
  • Corvaja C; Department of Medicine, University of Udine, Udine, Italy.
  • Taurelli Salimbeni B; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.
  • Nicolò E; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.
  • Puglisi F; Department of Clinical and Molecular Medicine, Oncology Unit, "la Sapienza" University of Rome, Azienda Ospedaliera Sant'Andrea, Rome, Italy.
  • Curigliano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.
Expert Opin Pharmacother ; 23(16): 1765-1770, 2022 11.
Article em En | MEDLINE | ID: mdl-36268855
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas Idioma: En Ano de publicação: 2022 Tipo de documento: Article